SBI-1997

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameSBI-1997
Drug Alias NameSBI1997
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSaronic Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSaronic Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A